J&J'S PLANNED ACQUISITION OF MENLO CARE PAVES WAY FOR VERSACATH
This article was originally published in The Gray Sheet
Executive Summary
J&J'S PLANNED ACQUISITION OF MENLO CARE PAVES WAY FOR VERSACATH introduction, nearly three years after the Menlo Care acute central venous catheter system received FDA 510(k) marketing clearance. Cleared in 1992, Versacath combines a Mainline single- lumen percutaneous introducer sheath and a Selectalumen single- or double-lumen inner catheter that can be inserted into the Mainline. The design allows Versacath to become a multi-lumen catheter for the administration of complex drug therapies.